Managed Care and Health Care Reform: Everything Old Is New Again

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010

“…68 Off-label drug use is just one aspect of the larger question about how to balance benefits, harms, and costs of medical interventions when technological advances are rapid, evidence is imperfect, and resources are finite.…”